tiprankstipranks
Advertisement
Advertisement

EVGN Stock Latest News

Evogene Expands ATM Offering as Shareholder Activism Escalates
Company AnnouncementsEvogene Expands ATM Offering as Shareholder Activism Escalates
1d ago
6K
EVGN
Evogene, BCDD announces strategic joint initiative
PremiumThe Fly
Evogene, BCDD announces strategic joint initiative
11d ago
EVGN
Evogene achieves integration of agentic systems with ChemPass AI platform
PremiumThe Fly
Evogene achieves integration of agentic systems with ChemPass AI platform
25d ago
EVGN
GOOG
Evogene Showcases AI-Driven ChemPass Platform and Expanded Google Cloud Collaboration in New Investor Deck
PremiumCompany Announcements
Evogene Showcases AI-Driven ChemPass Platform and Expanded Google Cloud Collaboration in New Investor Deck
1M ago
6K
EVGN
Evogene Sets Up $2.9 Million At-the-Market Share Offering With A.G.P.
PremiumCompany Announcements
Evogene Sets Up $2.9 Million At-the-Market Share Offering With A.G.P.
1M ago
6K
EVGN
Evogene says Phase 1 clinical study of BMC128 met primary endpoint
PremiumThe FlyEvogene says Phase 1 clinical study of BMC128 met primary endpoint
2M ago
EVGN
Evogene price target lowered to $2.15 from $2.25 at Alliance Global
Premium
The Fly
Evogene price target lowered to $2.15 from $2.25 at Alliance Global
2M ago
EVGN
Evogene Earnings Call: AI Momentum vs. Cash Strain
Premium
Company Announcements
Evogene Earnings Call: AI Momentum vs. Cash Strain
2M ago
EVGN
Evogene Tightens Focus on AI Small-Molecule Platform as Q1 2026 Revenue Falls
PremiumCompany Announcements
Evogene Tightens Focus on AI Small-Molecule Platform as Q1 2026 Revenue Falls
2M ago
6K
EVGN
Evogene reporta Q1 cont. ops. EPS (60c) vs. (26c) last year
PremiumThe Fly
Evogene reporta Q1 cont. ops. EPS (60c) vs. (26c) last year
2M ago
EVGN
Evogene’s Ag Plenus, Bayer End Herbicide Collaboration as APTH1 Target Falls Short
PremiumCompany Announcements
Evogene’s Ag Plenus, Bayer End Herbicide Collaboration as APTH1 Target Falls Short
2M ago
6K
EVGN
Evogene price target raised to $2.25 from $1.75 at Alliance Global
PremiumThe Fly
Evogene price target raised to $2.25 from $1.75 at Alliance Global
3M ago
EVGN
Evogene Faces Nasdaq Minimum Bid Price Deficiency, Granted Cure Period to September 2026
PremiumCompany AnnouncementsEvogene Faces Nasdaq Minimum Bid Price Deficiency, Granted Cure Period to September 2026
4M ago
6K
EVGN
Evogene receives Nasdaq minimum bid price notification
Premium
The Fly
Evogene receives Nasdaq minimum bid price notification
4M ago
EVGN
Evogene files to sell 5.08M ordinary shares for holders
Premium
The Fly
Evogene files to sell 5.08M ordinary shares for holders
4M ago
EVGN
Evogene price target lowered to $1.75 from $2.50 at Alliance Global
PremiumThe Fly
Evogene price target lowered to $1.75 from $2.50 at Alliance Global
4M ago
EVGN
Evogene Earnings Call: AI Ambition Meets Cash Reality
PremiumCompany Announcements
Evogene Earnings Call: AI Ambition Meets Cash Reality
4M ago
EVGN
Evogene Reshapes AI-Driven Molecule Business With 2025 Results and Strategic Overhaul
PremiumCompany Announcements
Evogene Reshapes AI-Driven Molecule Business With 2025 Results and Strategic Overhaul
5M ago
6K
EVGN
Evogene reports Q4 cont ops EPS (61c) vs. 17c last year
PremiumThe Fly
Evogene reports Q4 cont ops EPS (61c) vs. 17c last year
5M ago
EVGN
EVGN Earnings this Week: How Will it Perform?
PremiumPre-EarningsEVGN Earnings this Week: How Will it Perform?
5M ago
EVGN
Evogene Details 2025 Strategic Refocus Around ChemPass AI and Core Health, Agriculture Markets
Premium
Company Announcements
Evogene Details 2025 Strategic Refocus Around ChemPass AI and Core Health, Agriculture Markets
5M ago
6K
EVGN
Evogene collaborates with Queensland University in AI-driven cancer therapeutics
Premium
The Fly
Evogene collaborates with Queensland University in AI-driven cancer therapeutics
5M ago
EVGN

Trending

Name
Price
Price Change
SPX
S&P 500
―
DJIA
Dow Jones
―
NDX
Nasdaq 100
―
More Trending Stocks >